ISSN: 1574-8928

Journal Home

Journal Guideline

Recent Patents on Anti-Cancer Drug Discovery Q2 Unclaimed

Bentham Science Publishers B.V. United Arab Emirates

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Recent Patents on Anti-Cancer Drug Discovery is a journal indexed in SJR in Medicine (miscellaneous) and Drug Discovery with an H index of 52. It has an SJR impact factor of 0,54 and it has a best quartile of Q2. It has an SJR impact factor of 0,54.

Type: Journal

Type of Copyright:

Languages:

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Medicine (miscellaneous) (Q2) Cancer Research (Q3) Drug Discovery (Q3) Oncology (Q3) Pharmacology (medical) (Q3)

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

Recent Patents on Anti-Cancer Drug Discovery

0,54

SJR Impact factor

52

H Index

41

Total Docs (Last Year)

103

Total Docs (3 years)

3859

Total Refs

252

Total Cites (3 years)

100

Citable Docs (3 years)

2.51

Cites/Doc (2 years)

94.12

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Clinical Rheumatology Q2
Pharmacological Reports Q2
Journal of Human Nutrition and Dietetics Q2
Diseases of the Colon and Rectum Q2
Oncology Reports Q2

Compare this journals

Aims and Scope

Best articles by citations

Development of Taxol and Other Endophyte Produced Anti-Cancer Agents

Peptides Homing to Tumor Vasculature: Imaging and Therapeutics for Cancer

Meet Our Editorial Board Member

Compositions for Treatment of Cancer and Inflammation

Nanotechnology Advances in Brain Tumors: The State of the Art

Characterization of Solid Lipid Nanoparticles Containing Caffeic Acid and Determination of its Effects on MCF-7 Cells

Use of human Dihydroorotate Dehydrogenase (hDHODH) Inhibitors in Autoimmune Diseases and New Perspectives in Cancer Therapy

Author Index To Volume 1

Oncologic Imaging End-Points for the Assessment of Therapy Response

Recent Developments in Patent Anti-Cancer Agents Targeting the Matrix Metalloproteinases (MMPs)

Therapeutic Strategy of Advanced Hepatocellular Carcinoma by Using Combined Intra-Arterial Chemotherapy

Recent Patents on Bacterial Proteins as Potential Anticancer Agents

SHOW MORE ARTICLES

Histone Deacetylase Inhibitors: Recent Insights from Basic to Clinical Knowledge & Patenting of Anti-Cancer Actions

"Impact of Smoking Cessation Treatment" on Lung Function and Response Rate in EGFR Mutated Patients: A Short-Term Cohort Study

Calcium Channels and Prostate Cancer

Novel Systemic Drugs for Cutaneous T-Cell Lymphoma

Small Molecule Vascular Disrupting Agents: Potential New Drugs for Cancer Treatment

Activating Mutations of ESR1, BRCA1 and CYP19 Aromatase Genes Confer Tumor Response in Breast Cancers Treated with Antiestrogens

Therapeutic Transfer of DNA Encoding Adenoviral E1A

Integrin-Targeted Peptide- and Peptidomimetic-Drug Conjugates for the Treatment of Tumors

The Androgen Receptor as Putative Therapeutic Target in Hormone-Refractory Prostate Cancer

Editorial [Hot topic: Breast Cancer: Novel Therapeutic Targets (Guest Editor: George W. Yip)]

Editorial [Hot topic: Developing New Anti-Cancer Drugs (Guest Editor: Ricardo De Souza Pereira)]

The Potential Anti-Tumorigenic and Anti-Metastatic Side of the Proprotein Convertases Inhibitors